“…Nineteen studies to date have utilized the TrkB F616A mutants for analysis of TrkB signalling in studies on nociception (Renn et al, 2009;Wang et al, 2009), neuromuscular function (Greising et al, 2015), hypothalamic function (Bariohay et al, 2009;Byerly et al, 2013), inhibitory circuity maturation (Vandenberg et al, 2015), spinal cord injury (Zhan et al, 2013;Mantilla et al, 2014), traumatic brain injury (Aungst et al, 2013), motivated behaviour (Johnson et al, 2008), antidepressant drug signalling (Rantamäki et al, 2011), circadian rhythms (Girardet et al, 2013), retinal circuitry (Kaneko et al, 2008;Majumdar et al, 2011), tests of TrkB agonists (Jang et al, 2010;Choi et al, 2012), receptor sequestration (Mou et al, 2011), glucocorticoid receptor interaction (Arango-Lievano et al, 2015, and most recently, the interaction of RhoGTPase signalling (Hedrick et al, 2016). This body of research demonstrates that this transgenic line of mice is a valuable model for analyzing the influence of TrkB.FL receptor function.…”